Cytogenetic abnormalities in MALT lymphomas and their precursor lesions from different organs. A fluorescence in situ hybridization (FISH) study

Histopathology

Volumn 50, Issue 2, 2007, Pages 217-224

  Joao C ^a,b   Farinha, P ^c   Da Silva, M G ^a   Martins, C ^a   Crespo, M ^a   Cabecadas J ^a  

^a INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

^b MAYO CLINIC   (United States)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Cytogenetics; FISH; MALT; Non Hodgkin's lymphoma; Pathogenesis

Indexed keywords

PARAFFIN;

ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; HASHIMOTO DISEASE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; SJOEGREN SYNDROME; TRISOMY 12; TRISOMY 18;

CHROMOSOME ABERRATIONS; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; TRISOMY;

EID: 33846026333     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02580.x     Document Type: Article

References (37)

1. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-hodgkin's lymphoma. Blood 1997; 89; 3909-3918.
2. Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinct type of B-cell lymphoma. Cancer 1983; 52; 1410-1416.
3. Isaacson PG. Gastric MALT lymphoma: from concepts to cure. Ann. Oncol. 1999; 10; 637-645.
4. Lecuit M, Abachin E, Martin A et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N. Engl. J. Med. 2004; 350; 239-248.
5. Yeung L, Tsao YP, Chen PY et al. Combination of adult inclusion conjunctivitis and mucosa-associated lymphoid tissue (MALT) lymphoma in a young adult. Cornea 2004; 23; 71-75.
6. de la Fouchardiere A, Vandenesch F, Berger F. Borrelia-associated primary cutaneous MALT lymphoma in a nonendemic region'. Am. J. Surg. Pathol. 2003; 27; 702-703.
7. Hyjek E, Smith WJ, Isaacson PG. Primary B-cell lymphoma of salivary glands and its relationship to myoepithelial sialadenitis. Hum. Pathol. 1988; 19; 766-776.
8. Holm LE, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N. Engl. J. Med. 1985; 312; 601-604.
9. Hussel T, Isaacson PG, Crabtree JE et al. Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue. J. Pathol. 1996; 178; 122-127.
10. Dierlamm J, Pittaluga S, Wlodarska I et al. Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features. Blood 1996; 87; 1299-1307.
11. Farinha P, Gascoyne RD. Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma. J. Clin. Oncol. 2005; 23; 6370-6378.
12. Wotherspoon AC, Finn TM, Isaacson PG. Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue. Blood 1995; 85; 2000-2004.
13. Brynes RK, Almaguer PD, Leathery KE et al. Numerical cytogenetics abnormalities of chromosomes 3, 7, and 12 in marginal zone B-cell lymphomas. Mod. Pathol. 1996; 9; 995-1000.
14. Auer IA, Gascoyne RD, Connors JM et al. t(11;18)(q21;q21) is the most common translocation in MALT lymphomas. Ann. Oncol. 1997; 8; 979-985.
15. Rosenwald A, Ott G, Stilgenbauer S et al. Exclusive detection of the t(11;18)(q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas. Am. J. Pathol. 1999; 155; 1817-1821.
16. Zhang Q, Siebert R, Yan M et al. Inactivating mutations and over-expression of Bcl-10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;140(p22;q32). Nat. Genet. 1999; 22; 63-68.
17. Willis TG, Jadayel DM, Du MQ et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 1999; 96; 35-45.
18. Streubel B, Lamprecht A, Dierlamm J et al. t(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood 2003; 101; 2334-2339.
19. Sanchez-Izquierdo D, Buchonet G, Siebert R et al. MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma. Blood 2003; 101; 4539-4546.
20. Streubel B, Vinatzer U, Lamprecht A et al. t(3;14)(9p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia 2005; 19; 652-658.
21. Barth T, Bentz M, Leithauser F et al. Molecular-cytogenetic comparison of mucosa-associated marginal zone B-cell lymphoma and large B-cell lymphoma arising in the gastro-intestinal tract. Genes Chromosomes Cancer 2001; 31; 316-325.
22. Remstein ED, Kurtin PJ, James CD et al. Mucosa-associated lymphoid tissue lymphomas with t(11;18)(q21;q21) and mucosa-associated lymphoid tissue lymphomas with aneuploidy develop along different pathogenetic pathways. Am. J. Pathol. 2002; 161; 63-71.
23. Lucas CP, Yonezumi M, Inohara N et al. Bcl10 and MALT1, independent targets of chromosomal translocation in MALT lymphoma, cooperate in a novel NF-jB signaling pathway. J. Biol. Chem. 2001; 276; 19012-19019.
24. Gascoyne RD. Molecular pathogenesis of mucosal-associated lymphoid tissue (MALT) lymphoma. Leuk. Lymph. 2003; 44; S13-S20.
25. Ho L, Davis RE, Conne B et al. MALT1 and API2-MALT1 fusion act between CD40 and IKK and confer NF-jB dependent proliferative advantage and resistance against FAS-induced cell death in B cells. Blood 2005; 105; 2891-2909.
26. Schreuder MI, Hoeve MA, Hebeda KM et al. Mutual exclusion of t(11;18)(q21;q21) and numerical chromosomal aberrations in the development of different types of primary gastric lymphomas. Br. J. Haematol. 2003; 123; 590-599.
27. Hyytinen E, Visakorpi T, Kallioniemi A et al. Improved technique for analysis of formalin-fixed, paraffin-embedded tumors by fluoscence in situ hybridization. Cytometry 1994; 16; 93-99.
28. Alers JC, Krijtenburg PJ, Vissers KJ et al. Interphase in situ hybridization to disaggregated and intact tissue specimens of prostatic adenocarcinomas. Histochem. Cell Biol. 1995; 104; 479-486.
29. Ye H, Liu H, Attygalle A et al. Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CaA strains of H. pylori in gastric MALT lymphoma. Blood 2003; 102; 1012-1018.
30. Streubel B, Simonitsch-Klupp I, Mullauer L et al. Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia 2004; 18; 1722-1726.
31. Ye H, Gong L, Liu H et al. MALT lymphoma with t(14;18)(q32;q21) / IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression. J. Pathol. 2005; 205; 293-301.
32. Sugiyama T, Asaka M, Nakamura T et al. API2-MALT1 chimeric transcript is a predict marker for the responsiveness of H. pylori eradication treatment in low-grade gastric MALT lymphoma. Gastroenterology 2001; 120; 1884-1885.
33. Liu H, Ye H, Ruskone-Fourmestraux A et al. t(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 2002; 122; 1286-1294.
34. Starostik P, Patzner J, Greiner A et al. Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways. Blood 2002; 99; 3-9.
35. Isaacson PG, Du MQ. MALT lymphoma from morphology to molecules. Nat. Rev. Cancer 2004; 4; 644-653.
36. Gobbo Cesar AC, Calmon MF, Cury PM et al. Genetic alterations in benign lesions: chronic gastritis and gastric ulcer. World J. Gastroenterol. 2006; 12; 625-629.
37. Farinha P, Andre S, Cabecadas J, Soares J. High frequency of MALT lymphoma in a series of 14 cases of primary breast lymphoma. Appl. Immunohistochem. Mol. Morph. 2002; 10; 115-120.